For families living with cystic fibrosis, access to medication is not optional. Access is survival.
In September 2024, my then 29-year-old son, Nathan, stood frozen at the pharmacy counter. According to the pharmacist, his marketplace insurance plan declared, with the finality of concrete setting, that it would no longer cover his cystic fibrosis medications. The reason? He was covered under his mother's insurance.
He was not.
Having aged out of parental coverage at 26, he was left stranded. For a young man already carrying the weight of late diagnosis, repeated inequities in care, and the grief of family losses, this denial was more than ink on paper. It was a stone wall.
As a mother, I would do anything for my sons, both of whom have CF. But because they are adults, I wait for permission before stepping in. When Nathan agreed, I joined him in the fight: calls, letters, documentation, appeals. Each effort was met with the same verdict — no coverage, no access.
The Toll of Waiting Without Care
By October 2025, Nathan had gone 13 months without pancreatic enzymes, Pulmozyme, Trikafta, or any of the medications that sustain his quality of life.
He described to me the exhaustion of “pretending to function.” Cooking or eating a meal could become a setback. Even lying in bed felt laborious. He longed for some moment of normalcy but felt trapped. Often, he supported others while rarely feeling supported himself. His words echoed those of countless others with CF who describe the daily labor of survival — where even breathing feels like work.
Our talks remain rooted in my heart: the spiral of resignation, the burden of depending on his “village,” the longing for days that are simply decent. Without medication, even breathing was precarious. Without insurance’s approval, his existence felt conditional, his worth diminished.
And yet, he kept fighting.
A Face That Froze Me Still
On Oct. 23, 2025, on the way back from a pre-dawn walk to the waterfront in Seattle, I halted mid-step, drawn to a painting displayed at the corner of 1st Avenue and Bell Street. It was signed by Dr. Moe and dated April 24, 2015. It felt as though it had been waiting for me.
The face was fragmented, surreal, and deeply human. Geometric shards and cellular patterns mirrored the anatomy of struggle. The eyes — wide, layered, uneven — spoke of vigilance and fatigue. The mouth, distorted and closed, suggested silence held too long. Colors — blue, green, yellow, black — bled into one another like emotions refusing to stay in their lanes.
I saw my son in that face.
Thirteen months without medication had left Nathan experiencing life as labor, like the collage of effort and endurance that I now viewed. A composition of negotiated breath and invisible battles. I could see his lungs, pancreas, and every cell in his body in the distorted face that looked at me. And the inked lines became the rigid boundaries of insurance denials, boxing in a life that deserved fluidity and care.
A Conference That Sparked an Army
I was in Seattle to attend the North American CF Conference and speak at Symposium 06: Cure (or Close) for All. Surrounded by doctors, researchers, fellow parents, and advocates from around the world, I felt the power of community surge. My son’s story — his denials, his voicelessness — found new listeners.
With Nathan’s permission, I reached out to Dr. Meghan McGarry at Seattle Children’s Hospital about a new symptom he had observed. Emails and calls to doctors in New York followed. Compass, too, picked up his case again, after Nathan had dropped it due to sheer exhaustion.
Suddenly, the fight was no longer ours alone. Nathan’s team stretched beyond insurance companies and into human hearts. What had felt like a solitary battle became a group effort: care centers willing to see him without insurance, advocates carving paths to access, voices amplifying his own.
My son needed that army. He needed a community to restore hope when his own strength was worn thin.
The Sound of Care
One month after the conference, just two days before Thanksgiving, Nathan called me. His voice carried something I hadn’t heard in months: a little mischievousness and relief.
“Listen, Mom. What’s the rattling you hear?”
It was his Zen Pep prescription, finally in his hands, rattling a sweet victory song. We celebrated not just the medicine, but the refills marked on the bottle — signs of continued care.
The next day, Vertex called him. Then Compass emailed to confirm. Pulmozyme and a new modulator were on their way.
On Dec. 4 at 4:15 p.m., a Styrofoam box arrived. Inside were Pulmozyme and Alyftrek — tangible proof that persistence, advocacy, and community can break through walls.
Why Community Matters
This story is not about one young man and his mother. It is about the power of community — the chorus of doctors, advocates, organizations, and families who refused to let silence or bureaucracy win.
More than once, my son shared that all he wants is for his days to be “decent, not perfect.” That longing for decency — breathing without fear, eating without risk, living without denials, accessing medication — is what drives me to keep advocating for those who cannot benefit from modulators.
The rattling of his prescription bottle is the resounding sound of care, amplified by community. It is proof that when we join voices, we create marching music strong enough to move us toward the future we all hope for: closing the inequities in care, and finding a cure for every person with CF. Each step forward is carried by the chorus of families, care team providers, advocates, and researchers who refuse to give up.
Together, care becomes a reality. Together, a cure will become reality, too.
Interested in sharing your story? The CF Community Blog wants to hear from you.
